The committee’s latest report is not all that different from the one issued in 2015. However, their stance on editing embryos is more clear: The panel supports editing human embryos, but only under very specific circumstances. First, proper research needs to be conducted so that geneticists and doctors have a clear picture of the risks associated with this practice. Once that is understood, this editing should only be done to treat a disease or disability, and only if no other “reasonable alternatives” exist. Basically, if there is any other way to treat the embryo's condition—including waiting until the baby is born and then successfully editing their non-reproductive cells to cure the disease—then doctors should go that route. This narrows down the potential candidates to a very small pool: those babies who are guaranteed to have an incurable disease based on their parents' genes.